August 30, 2021 11:11 AM EDTUpdated 03:31 PM
News Briefing

Spring­Works teams with Dana-Far­ber to test BC­MA com­bo; VBL restarts PhI­II tri­al af­ter FDA clears gene ther­a­py batch­es

Paul Schloesser

Associate Editor

Spring­Works Ther­a­peu­tics has a new re­search part­ner.

The Con­necti­cut bio­phar­ma an­nounced to­day that it has start­ed a re­search col­lab­o­ra­tion with the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times